Department of Critical Care Medicine Peking University Third Hospital, Beijing 100191, China.
Biobank Peking University Third Hospital, Beijing 100191, China.
Mediators Inflamm. 2024 Sep 17;2024:4936265. doi: 10.1155/2024/4936265. eCollection 2024.
To explore and validate the value of clinical parameters combined with plasma biomarkers for predicting acute respiratory distress syndrome (ARDS) in patients of high risks in the surgical intensive care unit (SICU).
We conducted a prospective, observational study from January 2020 to December 2023, which enrolled 263 patients of high risks in the SICU of Peking University Third Hospital consecutively; they were classified as ARDS and non-ARDS according to whether ARDS occurred after enrollment. Collected clinical characteristics and blood samples within 24 hr of admission to SICU. Blood samples from the first day to the seventh day of SICU were collected from patients without ARDS, and patients with ARDS were collected until 1 day after ARDS onset, forming data based on time series. ELISA and CBA were used to measure plasma biomarkers. Endpoint of the study was the onset of ARDS. Cox proportional hazard regression analysis was used to find independent risk factors of the onset of ARDS, then constructed a nomogram and tested its goodness-of-fit.
About 84 of 263 patients ended with ARDS. Univariate analysis found 15 risk factors showed differences between ARDS and non-ARDS, namely, interleukin 6, interleukin 8 (IL-8), angiopoietin Ⅱ, LIPS, APACHEⅡ, SOFA, PaO/FiO, age, sex, shock, sepsis, acute abdomen, pulmonary contusion, pneumonia, hepatic dysfunction. We included factors with < 0.2 in multivariate analysis and showed LIPS, PaO/FiO, IL-8, and receptor for advanced glycation end-products (RAGE) of the first day were independent risk factors for ARDS in SICU, a model combining them was good in predicting ARDS (C-index was 0.864 in total patients of high risks). The median of the C-index was 0.865, showed by fivefold cross-validation in the train cohort or validation cohort. The calibration curve shows an agreement between the probability of predicting ARDS and the actual probability of occurrence. Decision curve analysis indicated that the model had clinical use value. We constructed a nomogram that had the ability to predict ARDS in patients of high risks in SICU.
LIPS, PaO/FiO, plasma IL-8, and RAGE of the first day were independent risk factors of the onset of ARDS. The predictive ability for ARDS can be greatly improved when combining clinical parameters and plasma biomarkers.
探讨并验证联合应用临床参数和血浆生物标志物预测外科重症监护病房(SICU)高危患者急性呼吸窘迫综合征(ARDS)的价值。
本前瞻性观察性研究于 2020 年 1 月至 2023 年 12 月连续纳入北京大学第三医院 SICU 的 263 例高危患者;根据患者入组后是否发生 ARDS 将其分为 ARDS 组和非 ARDS 组。收集患者入 SICU 后 24 小时内的临床特征和血液样本。非 ARDS 患者在 SICU 第 1 天至第 7 天采集血液样本,ARDS 患者在 ARDS 发病后第 1 天采集血液样本,形成基于时间序列的数据。采用 ELISA 和 CBA 测量血浆生物标志物。研究的终点为 ARDS 的发病。使用 Cox 比例风险回归分析寻找 ARDS 发病的独立危险因素,然后构建列线图并对其拟合优度进行检验。
263 例患者中约 84 例最终发生 ARDS。单因素分析发现,ARDS 组和非 ARDS 组之间有 15 个危险因素存在差异,即白细胞介素 6、白细胞介素 8(IL-8)、血管生成素 2、LIPS、急性生理学与慢性健康状况评分系统Ⅱ(APACHEⅡ)、序贯器官衰竭评估(SOFA)、动脉血氧分压/吸入氧浓度(PaO/FiO)、年龄、性别、休克、脓毒症、急性腹痛、肺挫伤、肺炎、肝功能障碍。多因素分析纳入了截断值 < 0.2 的因素,结果显示,LIPS、PaO/FiO、IL-8 和第 1 天的晚期糖基化终产物受体(RAGE)是 SICU 中 ARDS 的独立危险因素,它们联合构建的模型对 ARDS 的预测效果良好(高危患者总体的 C 指数为 0.864)。在训练队列或验证队列的 5 折交叉验证中,C 指数的中位数为 0.865。校准曲线显示预测 ARDS 的概率与实际发生率之间存在一致性。决策曲线分析表明,该模型具有临床应用价值。我们构建了一个列线图,能够预测 SICU 高危患者的 ARDS。
第 1 天的 LIPS、PaO/FiO、血浆 IL-8 和 RAGE 是 ARDS 发病的独立危险因素。联合临床参数和血浆生物标志物可显著提高 ARDS 的预测能力。